Czech Republic
Companies
The presence of countries from BMI's Emerging Europe Region in the Pharmaceutical Research and Manufacturers of America (PhRMA)'s Special 301 Submission 2010 remains largely equivalent...
2010-03-11Industry
BMI's expectation that the proposed 7% reductions in the Czech Republic's pricing and reimbursement scheme in January 2010 would cause maximum consumer prices to actually rise[1]...
2010-01-21Industry
BMI forecasts that pharmaceutical sales in Emerging Europe will grow by 125% over the next decade, representing a compound annual growth rate (CAGR) of 8.43%. With global sales projected...
2010-01-05Industry
A&D Pharma Holdings, the owner of Romania's leading pharmaceutical wholesale, sales and marketing services and retail business, has confirmed the acquisition of privately held...
2009-12-29Industry
Prospects for growth in the Czech Republic's US$4.2bn pharmaceutical market appear ominous for 2010, pending the resolution of challenges to pricing legislation proposed in late 2009....
2009-12-16Industry
BMI's regional outlook for pharmaceutical companies in Emerging Europe has improved marginally, following an update to our Pharmaceuticals & Healthcare Business Environment Ratings....
2009-10-30Industry
The role of the Czech Republic's State Institute for Drug Control (SÚKL) in collecting information about the prescribing and dispending of medicine has come under scrutiny, following...
2009-08-19Industry
The opposition Social Democrats (CSSD)'s plans to undermine healthcare reforms in the Czech Republic look more plausible than ever, after a crushing defeat for the Civic Democratic...
2008-10-24
